Total Payments
$284,974
2024 Payments
$140,828
Companies
34
Transactions
901
Medicare Patients
12,167
Medicare Billing
$2.9M
Payment Breakdown by Category
Other$157,919 (55.4%)
Consulting$58,775 (20.6%)
Travel$41,100 (14.4%)
Food & Beverage$26,636 (9.3%)
Education$478.43 (0.2%)
Research$65.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,919 | 50 | 55.4% |
| Consulting Fee | $58,775 | 19 | 20.6% |
| Travel and Lodging | $41,100 | 101 | 14.4% |
| Food and Beverage | $26,636 | 722 | 9.3% |
| Education | $478.43 | 8 | 0.2% |
| Unspecified | $65.50 | 1 | 0.0% |
Payments by Type
General
$284,908
900 transactions
Research
$65.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $99,142 | 121 | $0 (2024) |
| PFIZER INC. | $68,815 | 96 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31,458 | 174 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $27,397 | 55 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $18,850 | 61 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $12,010 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $9,912 | 22 | $0 (2024) |
| ABBVIE INC. | $4,754 | 128 | $0 (2024) |
| GENZYME CORPORATION | $3,368 | 20 | $0 (2024) |
| Dermavant Sciences, Inc. | $3,291 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,828 | 217 | Amgen Inc. ($55,717) |
| 2023 | $120,208 | 236 | Amgen Inc. ($43,279) |
| 2022 | $14,115 | 120 | Novartis Pharmaceuticals Corporation ($11,886) |
| 2021 | $1,381 | 53 | AbbVie Inc. ($557.33) |
| 2020 | $792.61 | 23 | AbbVie Inc. ($418.19) |
| 2019 | $2,646 | 85 | AbbVie, Inc. ($1,123) |
| 2018 | $3,425 | 118 | AbbVie, Inc. ($1,103) |
| 2017 | $1,578 | 49 | AbbVie, Inc. ($739.50) |
All Payment Transactions
901 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $89.20 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Inflammation | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Consulting Fee | Cash or cash equivalent | $4,025.00 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Travel and Lodging | In-kind items and services | $628.98 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Travel and Lodging | In-kind items and services | $172.54 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Travel and Lodging | Cash or cash equivalent | $115.03 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $104.97 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $53.67 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Dermatology | ||||||
| 12/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $1,294.35 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,480.00 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $38.32 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,505.00 | General |
| Category: Inflammation & Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $889.14 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.21 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,294.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $198.02 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $99.08 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,686.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,481 | 6,809 | $3.7M | $1.2M |
| 2022 | 42 | 2,514 | 4,174 | $2.1M | $532,102 |
| 2021 | 45 | 3,859 | 6,526 | $2.4M | $626,915 |
| 2020 | 39 | 3,313 | 5,205 | $2.0M | $536,049 |
Total Patients
12,167
Total Services
22,714
Medicare Billing
$2.9M
Procedure Codes
161
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 97 | 1,777 | $1.2M | $376,301 | 32.0% |
| 0394T | High dose rate electronic brachytherapy, external | Office | 2023 | 97 | 1,777 | $593,909 | $238,265 | 40.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 308 | 381 | $641,609 | $184,995 | 28.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 168 | 266 | $270,942 | $86,042 | 31.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 57 | 66 | $104,918 | $33,037 | 31.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 98 | 105 | $123,340 | $27,237 | 22.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 83 | 90 | $95,246 | $25,201 | 26.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 94 | 109 | $81,944 | $23,217 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 311 | $68,546 | $19,850 | 29.0% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 30 | 30 | $56,967 | $18,007 | 31.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 50 | 55 | $54,235 | $15,906 | 29.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 214 | 272 | $68,528 | $14,639 | 21.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 102 | 116 | $70,260 | $11,123 | 15.8% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 18 | 19 | $35,621 | $11,094 | 31.1% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 24 | 130 | $38,593 | $10,982 | 28.5% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 19 | 25 | $24,520 | $7,870 | 32.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 177 | 213 | $35,334 | $6,815 | 19.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 58 | 66 | $18,658 | $4,796 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $17,195 | $4,591 | 26.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 73 | 107 | $13,307 | $4,111 | 30.9% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 19 | 19 | $18,381 | $3,870 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 43 | $13,396 | $3,850 | 28.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 34 | 34 | $23,242 | $3,641 | 15.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 76 | $10,556 | $3,131 | 29.7% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 14 | 16 | $10,561 | $2,811 | 26.6% |
About Dr. Collin Blattner, D.O
Dr. Collin Blattner, D.O is a MOHS-Micrographic Surgery healthcare provider based in The Dalles, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1669868493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Collin Blattner, D.O has received a total of $284,974 in payments from pharmaceutical and medical device companies, with $140,828 received in 2024. These payments were reported across 901 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,919).
As a Medicare-enrolled provider, Blattner has provided services to 12,167 Medicare beneficiaries, totaling 22,714 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location The Dalles, OR
- Active Since 04/08/2015
- Last Updated 08/02/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1669868493
Products in Payments
- Otezla (Drug) $99,227
- LITFULO (Drug) $37,140
- DUPIXENT (Biological) $30,374
- CIBINQO (Drug) $28,982
- Sotyktu (Drug) $13,922
- Odomzo (Drug) $9,663
- COSENTYX (Drug) $7,597
- COSENTYX (Biological) $6,859
- VTAMA (Drug) $3,291
- EUCRISA (Drug) $2,390
- Humira (Biological) $2,197
- SKYRIZI (Biological) $1,334
- TALTZ (Drug) $1,175
- TREMFYA (Drug) $574.47
- Cimzia (Drug) $523.07
- Skyrizi (Biological) $417.70
- RINVOQ (Biological) $399.16
- Bimzelx (Biological) $379.29
- STELARA (Biological) $272.63
- REMICADE (Biological) $210.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.